Context: Parkinson's disease (PD) is the second common progressive neurodegenerative
disease, distressing older men and is prevalent Worldwide. Objectives: This article is aimed …

[Frontiers in Bioscience S6, 65-74, January 1, 2014] 65 Parkinson’s disease: a review Janice M.
Beitz1 1School of Nursing-Camd Page 1 [Frontiers in Bioscience S6, 65-74, January 1, 2014] …

The motor symptoms of Parkinson's disease can be reasonably treated and managed.
However, therapies to slow or prevent disease progression remain a focus of research …

Parkinson's disease (PD) is a chronic neurodegenerative disease associated with
substantial morbidity, increased mortality, and high economic burden. Of importance to …

PURPOSE OF REVIEW Parkinson disease is a common neurodegenerative disorder that
affects millions of people worldwide. Important advances in the treatment, etiology, and the …

Parkinson's disease (PD) is the second most common neurodegenerative disease in the
world. Still the only major text on the subject, the completely revised and updated second …

The Parkinson's disease research field is a rapidly moving one, as many of the relevant
processes underlying PD neurodegeneration are being deciphered, enabling novel …

Parkinson's disease (PD) is the second most common neurodegenerative condition affecting
patients in the UK after Alzheimer's disease. It is broadly classified as a 'movement …

Objective: Parkinson's disease (PD) is a progressive neurological disorder characterised by
a large number of motor and non-motor features that can impact on function to a variable …

Parkinson disease (PD) is the second most common neurodegenerative disorder after
Alzheimer disease and refers to the clinical presentation of bradykinesia, rigidity, tremor, and …